I942

CAS No. 868145-09-9

I942( —— )

Catalog No. M33988 CAS No. 868145-09-9

I942 is a novel, selective ACyclic nucleotide (NCN) EPAC1 agonist that activates exchange proteins to regulate inflammatory gene expression in human umbilical blood tubes and inhibit pro-inflammatory cytokine signaling associated with cardiovascular disease.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 227 In Stock
10MG 370 In Stock
25MG 606 In Stock
50MG 820 In Stock
100MG 1107 In Stock
200MG Get Quote In Stock
500MG 2260 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    I942
  • Note
    Research use only, not for human use.
  • Brief Description
    I942 is a novel, selective ACyclic nucleotide (NCN) EPAC1 agonist that activates exchange proteins to regulate inflammatory gene expression in human umbilical blood tubes and inhibit pro-inflammatory cytokine signaling associated with cardiovascular disease.
  • Description
    I942 is a first in class, selective non-cyclic nucleotide (NCN) EPAC1 agonist. I942 can attenuate proinflammatory cytokine signalling normally associated with cardiovascular diseases.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    GPCR/G Protein
  • Target
    cAMP
  • Recptor
    cAMP
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    868145-09-9
  • Formula Weight
    369.43
  • Molecular Formula
    C20H19NO4S
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 250 mg/mL (676.72 mM; Ultrasonic )
  • SMILES
    O(CC(NS(=O)(=O)C1=C(C)C=C(C)C=C1)=O)C2=CC3=C(C=C2)C=CC=C3
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Graeme Barker, et al. The Potential of a Novel Class of EPAC-Selective Agonists to Combat Cardiovascular Inflammation. J Cardiovasc Dev Dis. 2017 Dec 5;4(4):22.?
molnova catalog
related products
  • ESI-08

    ESI-08 is an effective antagonist of EPAC2 with an IC50 of 8.4 μM. ESI-08 selectively blocks cAMP-induced EPAC activation but not cAMP-mediated PKA activation.

  • CB1R Allosteric modu...

    CB1R Allosteric modulator 3 is a potent CB1R modulator that inhibits cAMP and β-Arrestin and can be used for the study of obesity and nicotine addiction.

  • ESI-05

    ESI-05 is a specific EPAC2 (exchange protein directly activated by cAMP 2) antagonist (IC50: 0.4 μM). ESI-05 inhibits cAMP-mediated activation of EPAC2, as well as EAPC2, mediated Rap1 activation.